Cargando…

Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report

The biological anakinra appears promising to halt cytokine storm syndrome seen in severe courses of COVID‐19. However, immunosuppression with anakinra may facilitate sepsis, necessitating continuous screening for bacterial superinfections.

Detalles Bibliográficos
Autores principales: Kaps, Leonard, Labenz, Christian, Grimm, Daniel, Schwarting, Andreas, Galle, Peter R., Schreiner, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752410/
https://www.ncbi.nlm.nih.gov/pubmed/33363865
http://dx.doi.org/10.1002/ccr3.3307
_version_ 1783625856288030720
author Kaps, Leonard
Labenz, Christian
Grimm, Daniel
Schwarting, Andreas
Galle, Peter R.
Schreiner, Oliver
author_facet Kaps, Leonard
Labenz, Christian
Grimm, Daniel
Schwarting, Andreas
Galle, Peter R.
Schreiner, Oliver
author_sort Kaps, Leonard
collection PubMed
description The biological anakinra appears promising to halt cytokine storm syndrome seen in severe courses of COVID‐19. However, immunosuppression with anakinra may facilitate sepsis, necessitating continuous screening for bacterial superinfections.
format Online
Article
Text
id pubmed-7752410
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77524102020-12-23 Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report Kaps, Leonard Labenz, Christian Grimm, Daniel Schwarting, Andreas Galle, Peter R. Schreiner, Oliver Clin Case Rep Case Reports The biological anakinra appears promising to halt cytokine storm syndrome seen in severe courses of COVID‐19. However, immunosuppression with anakinra may facilitate sepsis, necessitating continuous screening for bacterial superinfections. John Wiley and Sons Inc. 2020-09-15 /pmc/articles/PMC7752410/ /pubmed/33363865 http://dx.doi.org/10.1002/ccr3.3307 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Kaps, Leonard
Labenz, Christian
Grimm, Daniel
Schwarting, Andreas
Galle, Peter R.
Schreiner, Oliver
Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
title Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
title_full Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
title_fullStr Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
title_full_unstemmed Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
title_short Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
title_sort treatment of cytokine storm syndrome with il‐1 receptor antagonist anakinra in a patient with ards caused by covid‐19 infection: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752410/
https://www.ncbi.nlm.nih.gov/pubmed/33363865
http://dx.doi.org/10.1002/ccr3.3307
work_keys_str_mv AT kapsleonard treatmentofcytokinestormsyndromewithil1receptorantagonistanakinrainapatientwithardscausedbycovid19infectionacasereport
AT labenzchristian treatmentofcytokinestormsyndromewithil1receptorantagonistanakinrainapatientwithardscausedbycovid19infectionacasereport
AT grimmdaniel treatmentofcytokinestormsyndromewithil1receptorantagonistanakinrainapatientwithardscausedbycovid19infectionacasereport
AT schwartingandreas treatmentofcytokinestormsyndromewithil1receptorantagonistanakinrainapatientwithardscausedbycovid19infectionacasereport
AT gallepeterr treatmentofcytokinestormsyndromewithil1receptorantagonistanakinrainapatientwithardscausedbycovid19infectionacasereport
AT schreineroliver treatmentofcytokinestormsyndromewithil1receptorantagonistanakinrainapatientwithardscausedbycovid19infectionacasereport